medigraphic.com
Colegio de Medicina Interna de México.

2005, Number 6

<< Back Next >>

Med Int Mex 2005; 21 (6)

Biliary cirrhosis secondary to biliary calculus. A report of a case and literature review

Fermín CCA, López KS, Paredes SJG, Ruvalcaba AJ, Arana VMA, Arcos ZM, Nellen HH, Halabe CJ

Language: Spanish
References: 27
Page: 503-511
PDF size: 221.43 Kb.


ABSTRACT

Hepatic fibrosis occurs in response to several types of hepatic aggression. The most common causes are: hepatitis B and C and alcohol consumption, other causes include: immunological alterations, genetic abnormalities, non alcoholic steatohepatitis, associated to diabetes mellitus or other metabolic disorders and, finally, illnesses affecting chronic cholestasis. Secondary biliary cirrhosis occurs after a long period of obstruction of biliary ways, due to biliary calculus or stenosis. It is presented the case of a 64-year-old patient with signs of hepatic fibrosis and history of cholecystectomy. A bibliographic review of diagnostic and therapeutic approach of cholestasis and biliary cirrhosis is also presented.


REFERENCES

  1. Iredale J. Cirrosis: new research provides a basis for rational and targeted treatments. BMJ 2003;327:143-7.

  2. Dufor J-F, DeLellis R, Kaplan M. Reversibility of hepatic fibrosis in autoimmune hepatitis. Ann Intern Med 1997;127:981-5.

  3. Kuo-Shyang J, Shou-Chuan S, Hsein-Jar C, Bee-Fong C. Secondary biliary cirrhosis: a limiting factor in the treatment of hepatolitiasis. Arch Surg 1989;124:1301-5.

  4. Duffy J, Hines O, Liu J, et al. Improved survival for adenocarcinoma of the ampulla of Vater: fifty-five consecutive resections. J Gastroenterol 2003;138:941-50.

  5. Laso J. Diagnóstico diferencial en medicina interna. 1ª ed. New York: Harcourt-Brace, 1998.

  6. Moraca R, Lee T, Ryan J, Traverso W. Long-term biliary function after reconstruction of mayor bile duct injures with hepaticoduodenostomy or hepaticojejunostomy. Arch Surg 2002;137:889-94.

  7. Sabiston DC Jr. Textbook of surgery: the biological basis of modern surgical practice. 15th ed. Philadelphia: WB Saunders, 1997.

  8. Jeng K-S, Kuo-Shyang J, Ohta I, Fi-Sh Y. Reappraisal of the systematic management of complicated hepatolitiasis with bilateral intrahepatic biliary structures. Arch Surg 1996;131:141-7.

  9. Yi-Yin J, Miin-Fu C, Chia-Siu W, et al. Surgical treatment of hepatolithiasis: long-term results. Surgery 1996;120:509-14.

  10. Feldman M, Scharschmidt Sleisenger M, et al. Enfermedades gastrointestinales y hepáticas. 6ª ed. Buenos Aires: Panamericana, 2000.

  11. Kusano T, Isa T, Ohtsubo M, et al. Natural progression of untreated hepatolithiasis that shows no clinical signs at its initial presentation. J Clin Gastroenterol 2001;33:114-7.

  12. Pastor A, Collado PS, González Gallego J. Factors influencing the inhibition of biliary glutathione efflux induced by biliary obstruction. Life Sci 2000;68:69-79.

  13. Krähenbühl S, Krähenbühl-Glauser S, Stucki J, Gehr P, Reichen J. Stereological and functional analysis of liver mitochondria from rats with secondary biliary cirrhosis: impared mitocondrial metabolism and increased mitochondrial content per hepatocyte. Hepatology 1992;15:1167-72.

  14. Gross J, Reichen J, Zeltner T, Zimmermann A. The evolution of changes in quantitative liver function test in rat model of biliary cirrhosis: correlation with morphometric measurement of hepatocytes mass. Hepatology 1987;7(3):457-63.

  15. Krähenbühl S, Brass E. Fuel homeostasis and carnitine metabolism in rats with secondary biliary cirrosis. Hepatology 1991;14:927-34.

  16. Krähenbühl S, Stucki J, Reichen J. Reduced activity of the electron transport chain in liver mitochondria isolated from rats with secondary biliary cirrhosis. Hepatology 1992;15:1160-6.

  17. Yang W, Benjamín I, Moore K, Portmann B, Alexander B. The action of nitric oxide on hepatic haemodynamics during secondary biliary cirrhosis in the rat. Eur J Pharmacol 2003;461:41-48.

  18. Friedman S. Molecular regulation of hepatic fibrosis: an integrated cellular response to tissue injury. J Biol Chem 2000;275(4):2247-50.

  19. Iredale J, Benyon R, Pickering J. Mechanism of spontaneous resolution of rat liver fibrosis. J Clin Invest 1998;102:538-49.

  20. Corbin I, Buist R, Peeling J, et al. Hepatic 31PMRS in rat models of chronic liver disease: assessing the extent and progression of disease. Gut 2003;52:1046-53.

  21. Krähenbühl L, Shäfer M, Krähenbühl S. Reversibility of hepatic mitocondrial damage in rats with long-term cholestasis. J Hepatol 1998;28:1000-7.

  22. Krähenbühl L, Hagenbuch B, Berardi S, Shäfer M, Krähenbühl S. Rapid normalization of hepatic glycogen metabolism in rats with long-term bile duct ligation after biliodigestive anastomosis. J Hepatol 1999;31:656-63.

  23. Bonis P, Friedman S, Kaplan M. Is liver fibrosis reversible? N Engl J Med 2001;334:452-4.

  24. Hammel P, Couvelard A, O’Toole D, et al. Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med 2001;344:418-23.

  25. Meretto P, Angelucci E, Lucarelli G. Reversibility of cirrhosis in patients cured of talasemia by bone marrow transplantation. Ann Intern Med 2002;136:667-72.

  26. Dufor J-F, DeLellis R, Kaplan M. Reversibility of hepatic fibrosis in autoimmune hepatitis. Ann Intern Med 1997;127:981-5.

  27. Natarajan S, Theise N, Thung S, et al. Large-cell change of hepatocytes in cirrhosis may represent a reaction to prolonged cholestasis. Am J Surg Pathol 1997;21(3):312-8.




2020     |     www.medigraphic.com